Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

BIZARRE: Haemonetics - What They Never Told You

These Analysts Slash Their Forecasts On Haemonetics After Q1 Results

Haemonetics Corp (NYSE:HAE) reported upbeat earnings for the first quarter on Thursday.

Benzinga · Aug 8, 2025

The Latest Analyst Ratings For Haemonetics

9 analysts have shared their evaluations of Haemonetics (NYSE:HAE) during the recent three months, expressing a mix of bullish and bearish perspectives.

Benzinga · Dec 4, 2024

Raymond James Thinks Haemonetics Growth Is 'Underappreciated'

Earlier this week, Raymond James attended Haemonetics Corp's (NYSE:HAE) Investor Day, where the management team presented a new Long-Range Plan (LRP), including some upside on the profitability, outlining each business unit's positioning and pipeline. According to the analysts, the plan implies an upside to expectations, despite some conservatism and back-end weight. Raymond James rolled…

Benzinga · Jul 1, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Morgan Stanley Maintains Equal-Weight Rating for Haemonetics: Here's What You Need To Know

Morgan Stanley has decided to maintain its Equal-Weight rating of Haemonetics (NYSE:HAE) and raise its price target from $60.00 to $70.00. Shares of Haemonetics are trading up 1.46% over the last 24 hours, at $66.13 per share. A move to $70.00 would account for a 5.85% increase from the current…

Benzinga · Jul 1, 2022

4 Analysts Have This to Say About Haemonetics

Over the past 3 months, 4 analysts have published their opinion on Haemonetics (NYSE:HAE) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga · Jul 1, 2022

Needham Sees Reasonable Forecasts For Haemonetics, With Some Tailwinds

Haemonetics Corporation's (NYSE: HAE) analyst day later this month may include an update on its businesses, new products, margin outlook, and financial targets for FY24-FY26.

Benzinga · Jun 15, 2022

Haemonetics: Q4 Earnings Insights

Haemonetics (NYSE:HAE) reported its Q4 earnings results on Tuesday, May 10, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga · May 10, 2022

Read news from The Economist, FT, and more,
with one subscription

Analyst Ratings For Haemonetics

Analysts have provided the following ratings for Haemonetics (NYSE:HAE) within the last quarter:

Benzinga · Feb 9, 2022

Haemonetics Earnings Perspective: Return On Invested Capital

According to Benzinga Pro, during Q3, Haemonetics (NYSE:HAE) earned $23.23 million, a 56.38% increase from the preceding quarter. Haemonetics also posted a total of $259.77 million in sales, a 8.28% increase since Q2.

Benzinga · Feb 9, 2022

Why Haemonetics Shares Are Trading Higher Today?

Haemonetics Corporation (NYSE: HAE) posted

Benzinga · Feb 8, 2022

Recap: Haemonetics Q3 Earnings

Haemonetics (NYSE:HAE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Benzinga · Feb 8, 2022

Coverage From

Benzinga

People

Mike Matson

21 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.